The antiepileptic drug levetiracetam decreases the inositol 1,4,5-trisphosphate-dependent [Ca2+]i increase induced by ATP and bradykinin in PC12 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 720-730

  Cataldi, Mauro ^a   Lariccia, Vincenzo ^a   Secondo, Agnese ^a   Di Renzo, Gianfranco ^a   Annunziato, Lucio ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTICONVULSIVE AGENT; BRADYKININ; CALCIUM ION; ETIRACETAM; FURA 2; G PROTEIN COUPLED RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE; IONOMYCIN; RYANODINE; RYANODINE RECEPTOR; THAPSIGARGIN;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTICONVULSANTS; BRADYKININ; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; INOSITOL 1,4,5-TRISPHOSPHATE; PC12 CELLS; PIRACETAM; RATS;

EID: 18044370863     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.079327     Document Type: Article

References (40)

1. 2+ transients and epileptiform potentials in hippocampal neurons. Neuroreport 14:471-475.
2. Arganaraz GA, Silva JA Jr, Perosa SR, Pessoa LG, Carvalho FF, Bascands JL, Bader M, da Silva Trindade E, Amado D, et al. (2004) The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy. Brain Res 1006:114-125.
3. Bregola G, Varani K, Gessi S, Beani L, Bianchi C, Borea PA, Regoli D, and Simonato M (1999) Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy. Neuroscience 92:1043-1049.
4. Bymaster F, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, and Felder CC (2003) Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis and pilocarpine-induced seizure activity. Eur J Neurosci 17:1403-1410.
5. 3 cells. J Biol Chem 271:9441-9446.
6. Cox C, Metherate R, and Ashe JH (1994) Modulation of cellular excitability in neocortex: muscarinic receptor and second messenger-mediated actions of acetylcholine. Synapse 16:123-136.
7. 1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain. Brain Res 643:125-129.
8. Davies C, Clarke VR, Jane DE, and Collingridge GL(1995) Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones. Br J Pharmacol 116:1859-1869.
9. Den Hertog A, Hoiting B, Molleman A, Van den Akker J, Duin M, and Nelemans A (1992) Calcium release from separate receptor-specific intracellular stores induced by histamine and ATP in a hamster cell line. J Physiol (Lond) 454:591-607.
10. Dooley M and Plosker GL (2000) Levetiracetam: a review of its adjunctive use in the management of partial onset seizures. Drugs 60:871-893.
11. 2+ stores in LAN-1 human neuroblastoma cells. J Biol Chem 269:18021-18027.
12. 2 bradykinin receptors from cultured human fibroblasts. J Biol Chem 266:9442-9446.
13. Fitzsimonds R and Dichter MA (1996) Heterologous modulation of inhibitory synaptic transmission by metabotropic glutamate receptors in cultured hippocampal neurons. J Neurophysiol 75:885-893.
14. Fuks B, Gillard M, Michel P, Lynch B, Vertongen P, Leprince P, Klitgaard H, and Chatelain P (2003) Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines. Eur J Pharmacol 478:11-19.
15. Gereau RW 4th and Conn PJ (1995) Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. J Neurosci 15:6879-6889.
16. Greenwood R, Fan Z, McHugh R, and Meeker R (2000) Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides. Mol Cell Neurosci 16:233-243.
17. Hadar E, Yang Y, Sayin U, and Rutecki PA (2002) Suppression of pilocarpine-induced ictal oscillations in the hippocampal slice. Epilepsy Res 49:61-71.
18. 1 receptor mediated inhibition of GABA release from rat cerebral cortex. Neurochem Int 24:389-394.
19. Honchar M, Olney JW, and Sherman WR (1983) Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science (Wash DC) 220:323-325.
20. 3) receptors and epileptic seizure. Jpn J Psychiatry Neurol 43:465-468.
21. 2+ regulators in neurotransmitter release. Neuron 24:1003-1016.
22. Jin W, Sugaya A, Tsuda T, Ohguchi H, and Sugaya E (2000) Relationship between large conductance calcium-activated potassium channel and bursting activity. Brain Res 860:21-28.
23. Libri V, Constanti A, Zibetti M, and Postlethwaite M (1997) Metabotropic glutamate receptor subtypes mediating slow inward tail current (IADP) induction and inhibition of synaptic transmission in olfactory cortical neurones. Br J Pharmacol 120:1083-1095.
24. Löscher W, Honack D, and Rundfeldt C (1998) Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 284:474-479.
25. Lukyanetz E, Shkryl VM, and Kostyuk PG (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia 43:9-18.
26. Lynch B, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, and Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 101:9861-9866.
27. Margineanu D and Klitgaard H (2002) Levetiracetam: mechanism of action, in Antiepileptic Drugs (Levy RH, Mattson RH, Meldrum BS, and Perucca E eds) pp 419-427, Lippincott, Williams & Wilkins, Baltimore, MD.
28. Margineanu D and Klitgaard H (2003) Levetiracetam has no significant GABA-related effect on paired-pulse interaction in the dentate gyrus of rats. Eur J Pharmacol 466:255-261.
29. Milligan G (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol 64:1271-1276.
30. 3 muscarinic cholinergic receptor genes. Brain Res 810:9-15.
31. 2Y receptors. J Neurosci 23:7479-7488.
32. 2 bradykinin receptor expressed by PC12 pheochromocytoma cells. Proc Natl Acad Sci USA 91:4412-4416.
33. Pal S, Sun D, Limbrick D, Rafiq A, and DeLorenzo RJ (2001) Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium 30:285-296.
34. Reber BF, Stucki J, and Reuter H (1993) Unidirectional interaction between two intracellular calcium stores in rat phaeochromocytoma (PC12) cells. J Physiol 468:711-727.
35. Rigo J, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, et al. (2002) The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 136:659-672.
36. Suh B, Lee CO, and Kim KT (1995) Signal flows from two phospholipase C-linked receptors are independent in PC12 cells. J Neurochem 64:1071-1079.
37. Tizzano J, Griffey KI, and Schoepp DD (1995) Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology 34:1063-1067.
38. Verkhratsky A and Shmigol A (1996) Calcium-induced calcium release in neurones. Cell Calcium 19:1-14.
39. Wulfert E and Margineanu DG (1998) Thapsigargin inhibits bicuculline-induce epileptiform excitability in rat hippocampal slices. Neurosci Lett 243:141-143.
40. 2+ currents. Seizure 10:279-286.